The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer
Epidemiological evidence suggests that non-steroidal anti-inflammatory drugs (NSAIDs) which act as cyclooxygenase (COX-2) inhibitors may reduce breast cancer incidence by up to 20%. These agents are often taken for pain relief by older women with osteoarthritis. Age is the major risk factor for brea...
Main Authors: | Sarah L. Horn, Ian S. Fentiman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/5/1550/ |
Similar Items
-
Chemoprevention of Gastric Cancer: Non-steroidal Anti-inflammatory Drugs Including Aspirin
by: Kee Don Choi
Published: (2017-12-01) -
Estimation of tolerance of a domestic non-steroid anti-inflammatory drug in the postoperative period of extraction of cataracts
by: F. Bakhritdinova, et al.
Published: (2021-04-01) -
Role of Non-Steroidal Anti-Inflammatory Drugs in Gynecology
by: Anna Livshits, et al.
Published: (2010-07-01) -
National Cancer Institute Workshop on Chemopreventive Properties of Nonsteroidal Anti-Inflammatory Drugs: Role of COX-Dependent and -Independent Mechanisms
by: Daniel H. Hwang, et al.
Published: (2002-01-01) -
Research progress in regulation of non-steroidal anti-inflammatory drugs on immunocytes
by: YU Jing, LIU Ke, WANG Hai-yan, YAN Jun
Published: (2021-12-01)